Literature DB >> 19633054

Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease.

C Jara Sánchez1, C Olier Gárate2, J García-Donas Jiménez2, J Peñalver Párraga3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19633054     DOI： 10.1093/annonc/mdp374

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Severe thrombocytopenia related to trastuzumab infusion.

Authors:  Marina Mantzourani; Helen Gogas; Aikaterini Katsandris; John Meletis
Journal:  Med Sci Monit       Date:  2011-07

Review 2.  Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.

Authors:  Brian A Baldo
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

3.  Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy.

Authors:  Mallorie L Huff; Joshua A Kalter; Ramona E Chase; Ranju Gupta
Journal:  Cureus       Date:  2022-01-30

4.  Severe thrombocytopenia after trastuzumab retreatment: a case report.

Authors:  Maria Simona Pino; Catia Angiolini; Luisa Fioretto
Journal:  BMC Res Notes       Date:  2013-10-04

5.  Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer.

Authors:  Yuko Takano; Satoshi Furune; Yuki Miyai; Sachi Morita; Megumi Inoue; Tomoya Shimokata; Mihoko Sugishita; Ayako Mitsuma; Osamu Maeda; Yuichi Ando
Journal:  Int Cancer Conf J       Date:  2021-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.